CRISPR-Cas fluorescent cleavage assay coupled with recombinase polymerase amplification for sensitive and specific detection of Enterocytozoon hepatopenaei

• Main Authors: Suthasinee Kanitchinda, Jiraporn Srisala, Rungkarn Suebsing, Anuphap Prachumwat, Thawatchai Chaijarasphong
• Format: Article
• Language: English
• Published: Elsevier 2020-09-01
• Series: Biotechnology Reports
• Subjects: Enterocytozoon hepatopenaei; CRISPR-Cas12a; RPA; Lateral flow detection
• Online Access: http://www.sciencedirect.com/science/article/pii/S2215017X20301272

Enterocytozoon hepatopenaei (EHP) is a parasite that infects pacific whiteleg shrimp, Penaeus vannamei, causing growth retardation and uneven size distributions that lead to severe losses in shrimp productivity. Routine monitoring is crucial to timely prevention and management of EHP, but field-deployable diagnostic kits for EHP are still scarce. Here, we proposed the use of recombinase polymerase amplification (RPA) and CRISPR-Cas12a fluorescence assay, henceforth RPA-Cas12a, for detection of EHP. Targeting ptp2 gene, RPA-Cas12a could detect as few as 50 copies of DNA and showed no reactivity with closely related microsporidia. The entire procedure could be performed at a temperature close to 37 °C within 1 h. Naked eye visualization was possible with UV/blue-light excitation or lateral flow detection. Thus, RPA-Cas12a is a rapid, sensitive and specific detection platform that requires no sophisticated equipment and shows promise for on-site surveillance of EHP.